Histamine H3 Receptor Antagonist Enhances Neurogenesis and Improves Chronic Cerebral Hypoperfusion-Induced Cognitive Impairments
Chronic cerebral hypoperfusion (CCH) is a neurodegenerative disease, which induces cognitive impairments in the central nervous system (CNS). Histamine H3 receptor (H3R) is an autoreceptor involved in the modulation of neurogenesis and synaptic plasticity in the CNS. However, the role of H3R in CCH-...
Hlavní autoři: | Na Wang, Jing Ma, Jing Liu, Jiangong Wang, Cuilan Liu, Hua Wang, Yong Liu, Haijing Yan, Shujun Jiang |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
Frontiers Media S.A.
2020-01-01
|
Edice: | Frontiers in Pharmacology |
Témata: | |
On-line přístup: | https://www.frontiersin.org/article/10.3389/fphar.2019.01583/full |
Podobné jednotky
-
FTY720 Prevents Spatial Memory Impairment in a Rat Model of Chronic Cerebral Hypoperfusion via a SIRT3-Independent Pathway
Autor: Miao Zhang, a další
Vydáno: (2021-01-01) -
Enhancement of the anticonvulsant effect of the h3 histamine receptor blocker thioperamid against the use of pioglitazone
Autor: O. Yehorenko, a další
Vydáno: (2022-04-01) -
Cortex-specific transcriptome profiling reveals upregulation of interferon-regulated genes after deeper cerebral hypoperfusion in mice
Autor: Zengyu Zhang, a další
Vydáno: (2023-03-01) -
The involvement of central nervous system histamine receptors in psychological stress-induced exacerbation of allergic airway inflammation in mice
Autor: Tomomitsu Miyasaka, a další
Vydáno: (2016-09-01) -
Baseline Characteristics Associated with Good Collateral Status Using Hypoperfusion Index as an Outcome
Autor: Omar Hamam, a další
Vydáno: (2022-07-01)